Company Orexigen Therapeutics, Inc. Nasdaq
Equities
US6861643020
Biotechnology & Medical Research
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,887,033 | 18,887,033 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Orexigen Therapeutics, Inc.
3344 North Torrey Pines Court Suite 200
92037, La Jolla
+858-875-8600
http://www.orexigen.com![address Orexigen Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/30049593.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.13% | 122B | |
+19.65% | 113B | |
+19.21% | 26.49B | |
-23.84% | 19.4B | |
-18.05% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |